Ilana Kaufman

1.5k citations
24 papers · 479 indexed · h-index 12
Topics
Systemic Lupus Erythematosus Research (9 papers)Rheumatoid Arthritis Research and Therapies (8 papers)Spondyloarthritis Studies and Treatments (6 papers)

In The Last Decade

Ilana Kaufman

22 papers receiving 457 citations

Peers

Ilana Kaufman
Comparison fields: 5 of 77
  • Rheumatology 266
  • Immunology 159
  • Epidemiology 93
  • Hematology 90
  • Genetics 62
Replace Daniel Seoane‐Mato with:
Daniel Seoane‐Mato Spain
J. M. W. Hazes Netherlands
Noranna B. Warner United States
Elisa Astorri United Kingdom
Christian Huemer Austria
Vasiliki Galanopoulou Greece
Tiziana Tison Italy
Blanca Elena Ríos Gomes Bica Brazil
Emre Bılgın Türkiye
J García-Consuegra Spain
Ilana Kaufman relative to Daniel Seoane‐Mato Spain Daniel Seoane‐Mato's profile →
Citations per field
00.5×2.9×
Daniel Seoane‐Mato · 1×
Citations per year

Countries citing papers authored by Ilana Kaufman

Since Specialization
Citations

This map shows the geographic impact of Ilana Kaufman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilana Kaufman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilana Kaufman more than expected).

Fields of papers citing papers by Ilana Kaufman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilana Kaufman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilana Kaufman. The network helps show where Ilana Kaufman may publish in the future.

Co-authorship network of co-authors of Ilana Kaufman

This figure shows the co-authorship network connecting the top 25 collaborators of Ilana Kaufman. A scholar is included among the top collaborators of Ilana Kaufman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilana Kaufman. Ilana Kaufman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 6
3 19
4 23
5 0
6 85
7 20
8 5
9 21
10 35
11 2
12 2
13 2
14 2
15 36
16 8
17 35
18 45
19 82
20 17

About Ilana Kaufman

Ilana Kaufman is a scholar working on Rheumatology, Hematology and Nephrology, having authored 24 papers that have together received 479 indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (9 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Spondyloarthritis Studies and Treatments (6 papers). The work is most often cited by research in Rheumatology (266 citations), Hematology (90 citations) and Immunology (159 citations). Ilana Kaufman has collaborated with scholars based in Israel, United States and Switzerland. Frequent co-authors include Ori Elkayam, Dan Caspi, Daphna Paran, David Levartovsky, Iris Dotan, Michael Yaron, D. Paran, Hagit Matz, Victoria Furer and Irena Wigler. Their work appears in journals such as Annals of the Rheumatic Diseases, The Journal of Pediatrics and Vaccine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026